InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by BEHRENS M KATHLEEN, Director. Director active across 3 companies, notably Mimedx Group, INC.. Cumulatively, 13 disclosures have been recorded. The latest transaction was filed on 7 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€163,56944,191 shares@ €3.70140.016% mcap36.3% of flow
Common Stock
SEC:0001376339-22-000089:0·
0374 shares0
Common Stock
SEC:0001209191-22-022716:0·
02,953 shares0
Common Stock
SEC:0001209191-22-017349:0·
0211 shares0
Common Stock
SEC:0001209191-22-001216·
0211 shares0
Common Stock
SEC:0001209191-22-001216:0·
€44,7555,000 shares@ €8.951100.0% of flow
Common Stock
SEC:0001209191-21-070084·
€44,7555,000 shares@ €8.9510.0020% mcap50.0% of flow
Common Stock
SEC:0001209191-21-070084:0·
0211 shares0
Common Stock
SEC:0001209191-21-059184·
0211 shares0
Common Stock
SEC:0001209191-21-059184:0·
0211 shares0
Common Stock
SEC:0001209191-21-045193·
0211 shares0
Common Stock
SEC:0001209191-21-045193:0·
€143,51817,056 shares@ €8.41450.014% mcap100.0% of flow
Common Stock
SEC:0001376339-21-000073·
€143,51817,056 shares@ €8.41450.014% mcap31.9% of flow
Common Stock
SEC:0001376339-21-000073:0·
13 of 13 declarations
About BEHRENS M KATHLEEN
Kathleen M. Behrens is a Board Member at Mimédx Group, Inc., IGM Biosciences, Inc., and Sarepta Therapeutics, Inc. She brings her expertise to guide strategic decisions and ensure compliance within these companies.
